Tag: biotech
-
A Failed Trial Result Forces Ridgeline Therapeutics to Cut Its Bellwater Workforce
Ridgeline Therapeutics is cutting 45 jobs after its lead drug candidate failed a mid-stage clinical trial, a setback that tempers Foundry Row’s steady biotech growth narrative.
-
Fourteen Startups Join Forge Bellwater’s Biggest Cohort
Forge Bellwater has admitted 14 companies to its Foundry Row incubator, its largest cohort yet, spanning biotech, green-energy hardware and the incubator’s first AI-focused startup.
-
City and Kestrel Biologics Strike Deal on Foundry Row Parking Garage
The city and Kestrel Biologics will split the cost of a 600-space Foundry Row parking garage tied to the biotech firm’s hiring surge, a deal some residents say undercuts the neighborhood’s new transit line.
-
Foundry Row Is Running Out of Lab Space, and Biotech Firms Are Feeling It
Wet-lab vacancy in Foundry Row has fallen below 4 percent, a shortage that biotech executives say is already complicating expansion plans and pushing some companies to consider sites outside Bellwater.
-
Ibarra, Citing Biotech Turnaround, Says She Isn’t Done Yet
Mayor Renata Ibarra announced a bid for a third term Wednesday, pointing to falling unemployment and biotech-sector growth even as some council members say the recovery has bypassed Lowertown and Cedar Hollow.
-
Ibarra Casts Biotech Boom as Proof of a City Turning a Corner
Mayor Renata Ibarra’s State of the City address highlighted Foundry Row’s biotech-driven revenue growth, drawing praise from business leaders and criticism from council members who say Lowertown and other districts have yet to see the benefits.
-
Kincaid President Faircloth Launches $200 Million Capital Campaign
Kincaid University President Howard Faircloth launched a $200 million capital campaign directing money toward biotech labs, journalism school upgrades and financial aid.
-
Forge Bellwater Incubator Adds Second Floor as Demand for Space Grows
Forge Bellwater is adding a second floor of space at its Foundry Row incubator, nearly doubling its footprint after a year-long waiting list for bench space.
-
Bellwater State Breaks Ground on New Biomanufacturing Lab
Bellwater State broke ground on a $42 million biomanufacturing lab funded partly by Kestrel Biologics, aiming to close a persistent skills gap in the region’s growing biotech sector.
-
Kincaid’s Technology-Transfer Office Announces a Second Biotech Spinout
Kincaid University’s technology-transfer office has announced Halcyon Biotherapeutics, its second biotech spinout, built around a faculty lab’s autoimmune-disease research.